Male HFD-fed Glp1r fl/fl control mice and Glp1r Wnt1/ mice were treated IP with either vehicle or mGIPR-Ab/P1 every 6 days for 18 days
This included testing for factor V Leiden mutation, prothrombin gene mutation, protein C level, protein S level, antithrombin level, ANA, lupus anticoagulant, anticardiolipin antibody, beta 2 glycoprotein, and D-dimer level
Key Takeaways Explore the dual-action benefits of GLP-1 and GIP medications, which provide significant weight reduction alongside restorative anti-inflammatory effects on kidney tissues
Never increase your PlexusDx tirzepatide injection dose without explicit approval from your prescribing clinician, even if you feel you've plateaued in weight loss
doi: 10.1210/clinem/dgz150, 22